Analyst Price Targets — AMPH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 8, 2025 9:25 pm | — | Barclays | $30.00 | $26.01 | TheFly | Amphastar initiated with an Equal Weight at Barclays |
| March 21, 2025 10:48 am | David Amsellem | Piper Sandler | $32.00 | $28.29 | TheFly | Amphastar price target lowered to $32 from $36 at Piper Sandler |
| August 8, 2024 8:06 am | David Amsellem | Piper Sandler | $66.00 | $43.31 | StreetInsider | Amphastar Pharmaceuticals (AMPH) PT Lowered to $66 at Piper Sandler |
| May 23, 2024 8:45 am | David Amsellem | Piper Sandler | $71.00 | $43.31 | StreetInsider | Piper Sandler Reiterates Overweight Rating on Amphastar Pharmaceuticals (AMPH) |
| March 12, 2022 12:00 am | David Amsellem | Piper Sandler | $35.00 | $34.30 | Pulse 2.0 | Amphastar Pharmaceuticals (AMPH) Stock: Why The Price Jumped Up |
Latest News for AMPH
Amphastar Pharmaceuticals remains a 'Hold' as growth and margin headwinds persist amid its transition from generics to a proprietary pipeline. AMPH's legacy generics are declining, branded products face growth deceleration, and margins are pressured by product mix and rising R&D/SG&A costs. FY26 revenue guidance was cut to mid- to high-single-digit growth; AMP-007's contribution is uncertain, and preclinical…
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH - Get Free Report) gapped down prior to trading on Friday after Wells Fargo and Company lowered their price target on the stock from $34.00 to $30.00. The stock had previously closed at $26.49, but opened at $22.44. Wells Fargo and Company currently has an overweight rating on the
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2025 Earnings Call Transcript
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.73 per share, missing the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.92 per share a year ago.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMPH.
U.S. House Trading
No House trades found for AMPH.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.